Is a Minimum Inhibitory Concentration (MIC) of <=2/38 considered effective for antibiotic treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of MIC ≤2/38 in Antimicrobial Susceptibility Testing

An MIC of ≤2/38 (likely representing trimethoprim/sulfamethoxazole) indicates susceptibility of the organism to this antibiotic combination and suggests it would be effective for treatment, assuming the infection site allows adequate drug penetration. 1

Understanding MIC Values

MIC (Minimum Inhibitory Concentration) represents the lowest concentration of an antibiotic that prevents visible bacterial growth under standardized laboratory conditions. When interpreting MIC results:

  • The notation "≤2/38" indicates the organism is inhibited at or below this concentration of trimethoprim/sulfamethoxazole (TMP/SMX)
  • The "≤" symbol indicates the true MIC may be at or below this value 1
  • This value must be compared to established breakpoints to determine susceptibility category (susceptible, intermediate, or resistant)

Clinical Significance of This MIC

Susceptibility Interpretation

  • MIC values must be compared to standardized breakpoints established by organizations like CLSI (USA) or EUCAST (Europe) 1
  • For TMP/SMX, an MIC of ≤2/38 typically falls within the "susceptible" range for most common pathogens
  • Approximately 22% of recent US H. influenzae isolates were resistant to TMP/SMX, meaning 78% would likely show susceptibility with MICs similar to or lower than this value 2

Factors Affecting Treatment Success

Despite a susceptible MIC, several factors can impact clinical outcomes:

  1. Site of infection: Some antibiotics concentrate better at specific sites (e.g., urinary tract) 1
  2. Environmental conditions: pH, oxygen tension, and protein binding at the infection site may differ from laboratory conditions 2
  3. Bacterial load (inoculum effect): Higher bacterial densities can affect the actual MIC in vivo 3
  4. Host factors: Macrophages, complement, and other immune components may enhance antibiotic activity 2

Pharmacodynamic Considerations

The effectiveness of antibiotics depends on their pharmacodynamic properties:

  • TMP/SMX effectiveness correlates with the time the drug concentration exceeds the MIC (T>MIC) and the AUC:MIC ratio 2
  • For optimal bactericidal activity, the drug concentration should remain above the MIC for approximately 40-50% of the dosing interval 2
  • A susceptible MIC like ≤2/38 increases the likelihood of maintaining adequate drug concentrations above the MIC during treatment

Potential Pitfalls

Despite a susceptible MIC, be aware of these considerations:

  • Low-level resistance development: Even at sub-MIC concentrations (several hundred-fold below the MIC), resistant bacteria can be selected 4, 5
  • Laboratory variability: MIC results can be influenced by testing conditions, inoculum size, and media composition 6, 7
  • Bacterial persistence: Some infections may not respond despite susceptible MICs due to biofilm formation or intracellular persistence

Conclusion for Clinical Practice

When seeing an MIC of ≤2/38:

  • This generally indicates good susceptibility to TMP/SMX
  • Treatment is likely to be effective if other factors (drug penetration, patient compliance, absence of allergies) are favorable
  • Monitor clinical response despite favorable in vitro results, as laboratory susceptibility doesn't guarantee clinical success

Remember that while MIC provides valuable guidance, it represents only one factor in determining treatment success, and clinical response should always be monitored.

References

Guideline

Antimicrobial Susceptibility Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antibiotic susceptibility and resistance testing: an overview.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2000

Research

Determination of minimum inhibitory concentrations.

The Journal of antimicrobial chemotherapy, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.